Management of chronic hand eczema

@article{Diepgen2007ManagementOC,
  title={Management of chronic hand eczema},
  author={Thomas L. Diepgen and Tove Agner and Werner Aberer and J Berth-Jones and Frederic Cambazard and Peter Elsner and John McFadden and Pieter Jan Coenraads},
  journal={Contact Dermatitis},
  year={2007},
  volume={57}
}
Hand eczema (HE) is one of the most frequent skin diseases and has often a chronically relapsing course with a poor prognosis resulting in a high social and economic impact for the individual and the society. In this article, we highlight the results of an expert workshop on the ‘management of severe chronic hand eczema’ with the focus on the epidemiology, the burden of severe HE, its classification and diagnostic procedures, and the current status of treatment options according to an evidence… Expand

Paper Mentions

Interventional Clinical Trial
The purpose of this study is to investigate the safety and efficacy of alitretinoin in the treatment of severe chronic hand eczema that does not respond to treatment with potent… Expand
ConditionsEczema
InterventionDrug
Management of Chronic Hand Eczema.
TLDR
Switching from topical treatments should not be delayed to avoid sensitizations, time off work, and a negative impact on quality of life. Expand
Management of Chronic Hand Eczema.
TLDR
Switching from topical treatments should not be delayed to avoid sensitizations, time off work, and a negative impact on quality of life. Expand
Guidelines for the Diagnosis, Treatment, and Prevention of Hand Eczema
TLDR
These guidelines cover the diagnosis, prevention, and treatment of chronic hand eczema and highlight the role that primary care and occupational health physicians can play in the early management of this disease. Expand
Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges
TLDR
Chronic hand eczema patients may benefit from new topical and systemic therapeutics that specifically target abnormally expressed immune markers that are under investigation in recently completed or currently ongoing trials. Expand
Allitretinoin and chronic eczema of hands
TLDR
Hand eczema is a common dermatosis affecting the hands that causes substantial occupational, functional, social and psychological disability, including prolonged sick leave and unemployment, anxiety, low self-esteem, and social phobia. Expand
[New and rarley used treatment options for refractory hand eczema: local UVA-1 phototherapy, retinoids, calcineurin inhibitors].
TLDR
This work highlights new and rarely used approaches to treat chronic HE uncluding local UVA-1-phototherapy, retinoids including the new oral retinoid alitretinoin, and calcineurin inhibitors. Expand
Canadian Hand Dermatitis Management Guidelines
TLDR
These guidelines cover the epidemiology, burden, quality of life, etiology, diagnosis, classification, and prevention of HD and provide guidance on management using an approach that is as evidence based as possible. Expand
Alitretinoin: A Review in Severe Chronic Hand Eczema
TLDR
Oral alitretinoin is a useful treatment option for patients with severe chronic hand eczema unresponsive to potent topical corticosteroids, and data obtained in real-world studies were consistent with those observed in clinical trials. Expand
Topical Treatment of Hand Eczema: Calcineurin Inhibitors
TLDR
Tacrolimus ointment, in comparison with topical corticosteroids, seems to be equipotent in the treatment of dyshidrotic palmar eczema and allergic hand Eczema. Expand
Systemic Treatment of Hand Eczema: Retinoids
TLDR
Advantages and disadvantages for treatment with acitretin and alitretinoin will be discussed in this chapter. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 87 REFERENCES
Chronic eczematous dermatitis of the hands: a comparison of PUVA and UVB treatment.
TLDR
PUVA and UVB treatments are alternative treatment modalities in patients with recalcitrant chronic eczematous dermatitis of the hands and PUVA is superior to UVB. Expand
Ranitidine treatment of hand eczema in patients with atopic dermatitis: a double-blind, placebo-controlled trial.
TLDR
A placebocontrolled trial was conducted to determine whether ranitidine is effective in the treatment of chronic hand eczema in atopic patients. Expand
Quality of life and depression in a population of occupational hand eczema patients
TLDR
The aims of the study were to determine risk factors for low QoL, the frequency and severity of depression among OHE patients and changes inQoL and depression after 12 months of follow up. Expand
Superficial X‐ray therapy in the treatment of constitutional eczema of the hands
TLDR
The advantage bestowed by active X‐ray therapy was greatest 6 to 9 weeks after the start of treatment, but was still present after 18 weeks. Expand
Long‐term, intermittent treatment of chronic hand eczema with mometasone furoate
TLDR
It is concluded that long‐term, intermittent treatment of chronic hand eczema with mometasone furoate fatty cream is effective and safe. Expand
Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebo-controlled study.
TLDR
It is concluded that 30 mg of acitretin is efficacious and safe to use in patients with hyperkeratotic dermatitis of the palms, and after 4 weeks of treatment, a 51% reduction of all symptoms was observed among patients receiving ac itretin. Expand
Intermittent maintenance therapy in chronic hand eczema with clobetasol propionate and flupredniden acetate.
TLDR
It is suggested that an intermittent schedule is advantageous when using a corticosteroid of high potency when keeping the dermatitis in remission. Expand
Successful treatment of dyshidrotic hand eczema using tap water iontophoresis with pulsed direct current.
TLDR
Only those sides treated with tap water iontophoresis showed significant improvement, indicating the efficacy of this treatment in cases of dyshidrotic hand eczema. Expand
Novel treatment of chronic severe hand dermatitis with bexarotene gel
TLDR
Treatment of hand dermatitis with topical corticosteroids is effective, particularly for milder forms, but they often lose effectiveness with time and can produce skin atrophy. Expand
Comparison of topical PUVA with UVA for chronic vesicular hand eczema
TLDR
Topical PUVA was compared with UVA for the treatment of chronic vesicular hand eczema in a doubleblind randomized within-patient trial and both sides improved over the 8-week treatment period and both remained substantially better objectively and subjectively at 8 weeks' follow-up. Expand
...
1
2
3
4
5
...